Company Overview

Update
Founded:
1991
Founders:
James A. Bianco
Headquarters:
Seattle, WA
IPO:
Went Public on Mar 27, 1997
Stock:
NASDAQ:CTIC
Categories:
Biotechnology

Cell Therapeutics is a biopharmaceutical company developing oncology products for the treatment of cancer.

Description

Update

Cell Therapeutics, Inc., a biopharmaceutical company, develops, acquires, and commercializes oncology products for cancer treatment. Its development portfolio includes Pixantrone, a phase III trial product, for non-Hodgkin’s lymphoma; Brostallicin, which is in first-line Phase II study for the treatment of sarcoma; and OPAXIO, a chemotherapeutic agent for the potential treatment of non-small cell lung, ovarian, and other cancers. It has collaboration and licensing arrangements with Novartis International Pharmaceutical, Ltd.; and PG-TXL Company, L.P. The company was founded in 1991 and is headquartered in Seattle, Washington.

Current Team (6)

Update

Board Members and Advisors (10)

Update

Funding Rounds (5) - $85.10M

Update

Investors (1)

Update

Offices/Locations (1)

Update
  • Office

    501 Elliott Ave. W. #400

    Seattle, WA 98119

    USA

Images (1)

Update
  • Cd4b656d86ea873bdce76e61f433fb19